<DOC>
	<DOC>NCT00816972</DOC>
	<brief_summary>This was a 1-week study of desloratadine (DL) plus oxybutynin (OXY) at two dose levels in the treatment of post-nasal drip in participants with seasonal allergic rhinitis. Participants received either desloratadine twice a day, oxybutynin twice a day, desloratadine plus lower-dose oxybutynin twice a day, desloratadine plus higher-dose oxybutynin twice a day, or placebo for 7 days.</brief_summary>
	<brief_title>Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Subjects must: be &gt;=18 years of age, be free of any clinically significant disease that would interfere with study, other than seasonal allergic rhinitis (SAR), have a documented diagnosis of SAR for &gt;=2 years, have had a positive skinprick test, be sufficiently symptomatic at the Screening visit, for the 3 calendar days immediately prior to baseline visit, plus the AM of the baseline visit, the seven twicedaily runin diary PRIOR total nasal symptom scores must have totaled &gt;=42, the Total NonNasal Symptoms score must have totaled &gt;=28, and the total Post Nasal Drip score must have totaled &gt;=14, be in general good health. Subjects who have: certain medical conditions or medical histories, allergies to any of the components in any of the study medications, nasal structure abnormalities, dependency to nasal, oral, or ocular decongestants, nasal topical antihistamines, or nasal steroids, used any investigational drug use in past 30 days, received immunotherapy (desensitization) are pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>